Profile

Michael David Gautreaux, Ph.D.Wake Forest School of Medicine

Michael David Gautreaux, Ph.D.

Professor,

Contact Information

Academic: 336-716-4456 | Department: 336-716-5492

Email: mgautrea@wakehealth.edu

Education & Training

  • B.S., Louisiana State University & A&M College, 1987
  • Ph.D., LSU School of Medicine-Shreveport, 1994
  • Fellowship, Immunology, LSU School of Medicine-Shrevep, 1998

NPI Number

  • 1427129279
Michael David Gautreaux, Ph.D.

Michael David Gautreaux, Ph.D.

Professor, Pathology

Research Interests

Kidney Transplantation; Tissue Donors; Graft Survival; Complement C4; Gene Dosage
More »

Contact Information

Academic: 336-716-4456 | Department: 336-716-5492

Email: mgautrea@wakehealth.edu

Recent Publications

APOL1 genotype and kidney transplantation outcomes from deceased African American donors. Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND,.. Transplantation. 2016;100(1):194-202.

Dual kidney transplants from adult marginal donors successfully expand the limited deceased donor organ pool. Stratta RJ, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Palanisamy A, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, El-Hennawy H, Khan M, Rogers J.. Clin Transplant. 2016;30(4):380-392.

Single vs dual (en bloc) kidney transplants from donors less than or equal to 5 years of age: a single center experience. Al-Shraideh Y, Farooq U, El-Hennawy H, Farney AC, Palanisamy A, Rogers J, Orlando G, Khan M, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, Stratta RJ.. World J Transplant. 2016;6(1):239-248.

Deceased-donor apolipoprotein L1 renal-risk variants have minimal effects on liver transplant outcomes. Dorr CR, Freedman BI, Hicks PJ, Brown WM, Russell GB, Julian BA, Pastan SO, Gautreaux MD, Muthusamy A, Chinnakotla S, Hauptfeld V, Bray RA, Kirk AD, Divers J, Israni AK.. PLoS One. 2016;11(4):e0152775.

APOL1 genotyping: can it aid in donor selection? [abstract]. O'Shields EF, Palmer ND, Freeman BI [sic] Freedman BI, Kiger DF, Gautreaux MD.. Hum Immunol. 2016;77(Suppl 1):105.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. El Hennawy H, Farney A, Orlando G, Rogers J, Khan M, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Mangus M, Stratta R.. Am J Transplant. 2015;15(Suppl 1):75.

Pancreas transplantation in C-peptide positive patients: does 'type' of diabetes really matter?. Stratta RJ, Rogers J, Farney AC, Orlando G, El-Hennawy H, Gautreaux MD, Reeves-Daniel A, Palanisamy A, Iskandar SS, Bodner JK.. J Am Coll Cardiol. 2015;220(4):716-727.

Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. Freedman BI, Julian BA, Pastan SO, Israni AK, Schladt D, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Hicks PJ, Palmer ND, Adams PL,.. Am J Transplant. 2015;15(6):1615-1622.

Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation. Ma J, Divers J, Palmer ND, Julian BA, Israni AK, Schladt D, Pastan SO, Chattrabhuti K, Gautreaux MD, Hauptfeld V, Bray RA, Kirk AD, Brown WM, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Guan M, Palanisamy A, Reeves-Daniel AM, Bowden DW,.. Kidney Int. 2015;88(3):584-592.

Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor. Palanisamy A, Persad P, Koty PP, Douglas LL, Stratta RJ, Rogers J, Reeves-Daniel AM, Orlando G, Farney AC, Beaty MW, Pettenati MJ, Iskandar SS, Grier DD, Kaczmorski SA, Doares WH, Gautreaux MD, Freedman BI, Powell BL.. Case Rep Nephrol. 2015;2015():821346.

Import pancreas transplants: good from far or far from good? [abstract]. Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, El-Hennawy H, Khan M, Gautreaux M, Iskandar S, Stratta R.. Am J Transplant. 2015;15(Suppl 3):1068.

Primary non function after deceased donor kidney transplantation: risks and consequences [abstract]. Al-Shraideh Y, Stratta R, Farney A, Orlando G, Palanisamy A, Reeves-Daniel A, Bodner J, Uloko V, Winfrey S, Kaczmorski S, Doares W, Mangus M, Gautreaux M, Iskandar S, Rogers J.. Transplantation. 2014;98(Suppl 1):631.

7 year results of a prospective randomized study of alemtuzumab vs rabbit anti-thymocyte globulin induction in kidney and kidney pancreas transplantation [abstract]. Farney A, Rogers J, Doares W, Iskandar S, Orlando G, Adams P, Gautreaux M, Kaczmorski S, Stratta R.. Transplantation. 2014;98(Suppl 1):90.

Similar results with solitary pancreas transplantation compared to simultaneous pancreas-kidney transplantation in the new millennium [abstract]. Rogers J, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Iskandar S, Gautreaux M, Doares W, Kaczmorski S, Stratta R.. Transplantation. 2014;98(Suppl 1):854.

Does donor ethnicity influence kidney transplant outcome after simultaneous kidney-pancreas transplantation? [abstract]. Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, Farooq U, Al-Shraideh Y, Winfrey S, Uloko V, Bodner J, Doares W, Kaczmorski S, Gautreaux M, Iskandar S, Freedman B, Stratta R.. Transplantation. 2014;98(Suppl 1):861.

Expanded criteria donors: the end of an era [abstract]. Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Mangus M, Rogers J.. Transplantation. 2014;98(Suppl 1):654.

Experience with deceased donor kidney transplantation in 114 septuagenarians [abstract]. Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Iskandar S, Gautreaux M, Rogers J.. Transplantation. 2014;98(Suppl 1):600.

Dual kidney transplants from adult marginal donors: double or nothing [abstract]. Stratta R, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Iskandar S, Gautreaux M, Farney A.. Transplantation. 2014;98(Suppl 1):595-596.

Influence of recipient age on deceased donor kidney transplant outcomes in the expanded criteria donor era. Al-Shraideh Y, Farooq U, Farney AC, Palanisamy A, Rogers J, Orlando G, Buckley MR, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, Stratta RJ.. Clin Transplant. 2014;28(12):1372-1382.

Pancreas transplantation: the Wake Forest experience in the new millennium. Rogers J, Farney AC, Orlando G, Iskandar SS, Doares W, Gautreaux MD, Kaczmorski S, Reeves-Daniel A, Palanisamy A, Stratta RJ.. World J Diabetes. 2014;5(6):951-961.

16th IHIW: global distribution of extended HLA haplotypes. Askar M, Daghstani J, Thomas D, Leahy N, Dunn P, Claas F, Doran S, Saji H, Kanangat S, Karoichane M, Tambur A, Monos D, El-Khalifa M, Turner V, Kamoun M, Mustafa M, Ramon D, Gandhi M, Vernaza A, Gorodezky C,.. Int J Immunogenet. 2013;40(1):31-38.

Transplantation of CDC high risk kidneys: a low risk option for a high risk problem [abstract]. Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Gautreaux M, Winfrey S, Uloko V, Iskandar S, Brim E, Hairston G, Stratta R.. Am J Transplant. 2013;13(Suppl 5):403.

Increased antibody detection with expanded panel of antigens in lifecodes class II IDV2 (LM2Q) [abstract]. Boldt B, Burton M, McDougan F, Kimball P, Stewart JW, Brown SB, Gautreaux M.. Hum Immunol. 2013;74(5):491.

Genotypic variation and outcomes in kidney transplantation: donor and recipient effects [commentary]. Gautreaux MD, Freedman BI.. Kidney Int. 2013;84(3):431-433.

Similar results with solitary pancreas compared to simultaneous kidney-pancreas transplantation in the new millennium [abstract]. Rogers J, Farney A, Iskandar S, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Doares W, Kaczmorski S, Gautreaux M, Stratta RJ.. Transplantation. 2013;96(6 Suppl):S11.

Long-term results of a prospective randomized study of alemtuzumab vs rabbit anti-thymocyte globulin induction in kidney and kidney pancreas transplantation [abstract]. Farney A, Rogers J, Hart L, Doares W, Iskandar S, Orlando G, Adams P, Gautreaux M, Kaczmorski S, Stratta R.. Am J Transplant. 2012;12(Suppl 3):56.

Does alemtuzumab induction and negative flow cytometry crossmatching abrogate the need for early graft biopsies in the setting of delayed graft function? [abstract]. McArthur MC, Iskandar S, Farney A, Gautreaux M, Doares W, Kaczmorski S, Ghanta M, Reeves-Daniel A, Orlando G, Stratta RJ, Rogers J.. Am J Transplant. 2012;12(Suppl 3):372.

Primary non function after deceased donor kidney transplantation: risks and consequences [abstract]. Rogers J, Farney A, Orlando G, Brim E, Hairston G, Reeves-Daniel A, Ghanta M, Doares W, Kaczmorski S, Gautreaux M, Iskandar S, Winfrey S, McArthur MC, Uloko V, Stratta R.. Am J Transplant. 2012;12(Suppl 3):246-247.

Influence of donor and recipient ethnicity on outcomes following deceased donor kidney transplantation [abstract]. Winfrey SA, Al-Geizawi S, Farney A, Gautreaux M, Doares W, Kaczmorski S, Ghanta M, Reeves-Daniel A, Orlando G, Stratta RJ, Rogers J.. Am J Transplant. 2012;12(Suppl 3):524.

DP or not DP? That is the question [abstract]. Brown SB, Kiger DF, Rogers J, Gautreaux MD.. Hum Immunol. 2012;73(Suppl 1):62.

Time ain't on our side: real-time PCR for deceased donor typings [abstract]. O'Shields EF, Kiger DF, Gautreaux MD.. Hum Immunol. 2012;73(Suppl 1):142.

Back to the future: heat-treating for solid phase antibody testing [abstract]. Stewart JW, O'Shields EF, Kiger DF, Gautreaux MD.. Hum Immunol. 2012;73(Suppl 1):62.

Experience with deceased donor kidney transplantation in patients over age 70: is rationing justified? [abstract]. Algeizawi S, Farney A, Rogers J, Reeves-Daniel A, Doares W, Winfrey S, Kaczmorski S, Gautreaux M, Iskandar S, Adams P, Stratta R.. Am J Transplant. 2011;11(Suppl 1):74.

The APOL1 gene and allograft survival after kidney transplantation. Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, Langefeld CD, Bowden DW, Hicks PJ, Stratta RJ, Lin J-J, Kiger DF, Gautreaux MD, Divers J, Freedman BI.. Am J Transplant. 2011;11(5):1025-1030.

Effect of high donor BMI on short term outcomes in expanded criteria deceased donor kidney transplants (DDKT) [abstract]. Algeizawi S, Farney A, Rogers J, Gautreaux M, Doares W, Kaczmorski S, Winfrey S, Ghanta M, Reeves-Daniel A, Adams P, Stratta R.. Am J Transplant. 2011;11(Suppl 2):228.

Are HIV-positive patients at higher risk for BK viral infection following kidney transplantation? [abstract]. Kaczmorski S, Doares W, Al-Geizawi S, Gautreaux M, Reeves-Daniel A, Adams P, Ghanta M, Rogers J, Farney A, Stratta R.. Am J Transplant. 2011;11(Suppl 2):259.

Incorporating a urinary biomarker assay into clinical laboratory practice [abstract]. Gautreaux MD, Kiger DF, Winfrey SC, Farney AF [sic] [Farney AC], Rogers J, Beane KN, Victor B, Stewart JW, Stratta RJ.. Am J Transplant. 2011;11(Suppl 2):270.

Simultaneous kidney-pancreas transplantation in African-American recipients: alemtuzumab versus rATG induction [abstract]. Rogers J, Farney A, Al-Geizawi S, Doares W, Kaczmorski S, Winfrey S, Gautreaux M, Hart L, Iskandar S, Adams P, Hairston G, Stratta R.. Am J Transplant. 2011;11(Suppl 2):436.

Millions of dollars baby: is use of IVIG to prevent rejection in sensitized renal and pancreas transplant recipients effective? [abstract]. Doares W, Kaczmorski S, Williamson J, Al-Geizawi S, Gautreux M [sic] [Gautreaux M], Reeves-Daniel A, Adams P, Rogers J, Farney A, Stratta R.. Am J Transplant. 2011;11(Suppl 2):450-451.

Long-term outcomes of solitary pancreas transplantation: do surveillance pancreas biopsies level the playing field? [abstract]. Rogers J, Iskandar S, Farney A, Al-Geizawi S, Reeves-Daniel A, Ghanta M, Doares W, Kaczmorski S, Gautreaux M, Adams P, Stratta R.. Am J Transplant. 2011;11(Suppl 2):431.

70 deceased donor kidney transplants in patients over age 70: is 70 the new 50? [abstract]. Al-Geizawi S, Farney A, Rogers J, Reeves-Daniel A, Ghanta M, Winfrey S, Gautreaux M, Doares W, Kaczmorski S, Adams P, Stratta R, et al.. Am J Transplant. 2011;11(Suppl 2):241.

Pancreas transplantation: lessons learned from a decade of experience at Wake Forest Baptist Medical Center. Rogers J, Farney AC, Al-Geizawi S, Iskandar SS, Doares W, Gautreaux MD, Hart L, Kaczmorski S, Reeves-Daniel A, Winfrey S, Ghanta M, Adams PL, Stratta RJ.. Rev Diabet Stud. 2011;8(1):17-27.

Hypertension in standard criteria deceased donors is associated with inferior outcomes following kidney transplantation. Singh RP, Farney AC, Rogers J, Gautreaux M, Reeves-Daniel A, Hartmann E, Doares W, Iskandar S, Adams P, Stratta RJ.. Clin Transplant. 2011;25(4):E437-E446.

A urinary biomarker assay in clinical practice [abstract]. Beane KN, Stewart JW, Kiger DF, Rogers J, Gautreaux MD.. Hum Immunol. 2011;72(Suppl 1):S67.

Eliminating the red menace [abstract]. Brown SB, Kiger DF, O'Shields EF, Gautreaux MD.. Hum Immunol. 2011;72(Suppl 1):S161.

Comparison of DNA quantity and quality from different deceased donor sources isolated by an automatic system [abstract]. O'Shields EF, Kiger DF, Petty CC, Franz J, Gautreaux MD.. Hum Immunol. 2011;72(Suppl 1):S163.

Gauging the guess: comparing virtual crossmatching to the real thing [abstract]. Gautreaux MD, Kiger DF, Farney AC, Rogers J, Hartmann EL, Reeves-Daniel A, Al-Gezawi SM, Stratta RJ.. Am J Transplant. 2010;10(Suppl 4):190.

Infection or rejection: chicken or egg? [abstract]. Farney AC, Rogers J, Al-Geizawi S, Reeves-Daniel A, Hartmann E, Adams P, Gautreaux M, Winfrey S, Iskandar S, Stratta R, et al.. Am J Transplant. 2010;10(Suppl 4):320.

Experience with deceased donor kidney transplantation in patients over age 70: better late than never! [abstract]. Al-Geizawi S, Hartmann E, Farney A, Rogers J, Reeves-Daniel A, Winfrey S, Gautreaux M, Iskandar S, Adams P, Stratta R, et al.. Am J Transplant. 2010;10(Suppl 4):335-336.

Baseline biopsies of live donor renal allografts: 'you can observe a lot just by watching' [abstract]. Rogers J, Farney A, Iskandar S, Reeves-Daniel A, Hartmann E, Al-Geizawi S, Winfrey S, Gautreaux M, Adams P, Stratta R, et al.. Am J Transplant. 2010;10(Suppl 4):535.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Pathology

Michael David Gautreaux, Ph.D.

Michael David Gautreaux, Ph.D.

Professor, Pathology

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.